Pfizer-BioNTech Covid Vaccine Gets Full FDA Approval

The video discusses the importance of full vaccine approval by the Biden administration and US health officials to boost confidence among hesitant Americans. It highlights the potential for increased mandates by employers and educational institutions. The regulatory process for full approval is distinct from emergency use authorization. The approval is crucial for Pfizer and Biontech's business sustainability, with significant revenue projections.

What is the main reason the Biden administration is seeking full approval for the vaccine?

• To eliminate the need for masks

• To reduce vaccine costs

• To boost confidence among hesitant Americans

• To increase vaccine production

What is the difference between full approval and emergency use designation?

• Emergency use requires more data than full approval

• Full approval is temporary, while emergency use is permanent

• Full approval involves a more comprehensive review of data

• Emergency use is only for non-pandemic situations

Which companies have not yet applied for full approval of their vaccines?

• Pfizer and Biontech

• Moderna and J&J

• AstraZeneca and Novavax

• Sinovac and Sputnik V

What is one potential outcome of full vaccine approval for institutions?

• They can reduce vaccine doses

• They can increase tuition fees

• They can mandate vaccines with more confidence

• They can stop all health protocols

How is full approval expected to impact Pfizer and Biontech's business model?

• It will decrease their revenue

• It will ensure a sustainable business model

• It will lead to a merger with Moderna

• It will eliminate the need for further research